3-Hydroxy-2-quinoxalinecarboxylic acid - CAS 1204-75-7
Catalog: |
BB004884 |
Product Name: |
3-Hydroxy-2-quinoxalinecarboxylic acid |
CAS: |
1204-75-7 |
Synonyms: |
3-oxo-4H-quinoxaline-2-carboxylic acid |
IUPAC Name: | 3-oxo-4H-quinoxaline-2-carboxylic acid |
Description: | 3-Hydroxy-2-quinoxalinecarboxylic acid (CAS# 1204-75-7) is a useful research chemical. |
Molecular Weight: | 190.16 |
Molecular Formula: | C9H6N2O3 |
Canonical SMILES: | C1=CC=C2C(=C1)NC(=O)C(=N2)C(=O)O |
InChI: | InChI=1S/C9H6N2O3/c12-8-7(9(13)14)10-5-3-1-2-4-6(5)11-8/h1-4H,(H,11,12)(H,13,14) |
InChI Key: | NMOWGWOAPRKWIR-UHFFFAOYSA-N |
Boiling Point: | 432.4 °C at 760 mmHg |
Melting Point: | 267-268 °C (lit.) |
Purity: | 95 % |
Density: | 1.56 g/cm3 |
Appearance: | Green-yellow powder and chunks |
MDL: | MFCD00006726 |
LogP: | 1.03360 |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2021119554-A1 | Compositions and methods for potentiating immune activity | 20191212 |
KR-102230604-B1 | Method of manufacturing light-sensitive photochromic device and the device thereof | 20190507 |
KR-20200128795-A | Method of manufacturing light-sensitive photochromic device and the device thereof | 20190507 |
JP-2020069686-A | Breathable waterproof sheet and manufacturing method thereof | 20181030 |
CN-111106342-A | Lithium battery | 20181026 |
PMID | Publication Date | Title | Journal |
20148216 | 20100227 | Excited state intramolecular proton transfer (ESIPT) in six-coordinated zinc(ii)-quinoxaline complexes with ligand hydrogen bonds: their fluorescent properties sensitive to axial positions | Dalton transactions (Cambridge, England : 2003) |
17478894 | 20070501 | trans-Bis(dimethyl sulfoxide-kappaO)bis(3-oxo-3,4-dihydroquinoxaline-2-carboxylato-kappa2N1,O2)copper(II) | Acta crystallographica. Section C, Crystal structure communications |
2872934 | 19860514 | Absence of side-effects in the anticonvulsant action of cortically applied antagonists of N-methyl-D-aspartate | Brain research |
Complexity: | 311 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 190.03784206 |
Formal Charge: | 0 |
Heavy Atom Count: | 14 |
Hydrogen Bond Acceptor Count: | 4 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 190.03784206 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 78.8 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 1.2 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Quinoxalines
-
[2379-56-8]
6-Nitro-2,3-dihydroxyquinoxaline
-
[2756334-24-2]
7-Bromo-8-fluoro-3-methyl-3,4-dihydroquinoxalin-2(1H)-one
-
[2756334-26-4]
7-Bromo-8-fluoro-3-methylquinoxalin-2(1H)-one
-
[1628908-19-9]
5-Bromo-7-fluoroquinoxaline
-
[1562581-18-3]
(2S,3S,4aR,8aR)-2,3-Bis[2-(diphenylphosphino)phenyl]-1,4-dimethyldecahydroquinoxaline
-
[1416352-00-5]
1-(3-Chlorobenzyl)-1,2,3,4-tetrahydroquinoxaline Dihydrochloride
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS